CD4 and tuberculosis: Since 2011, the treatment was given to patients with CD4 cell count of less than 350 cells/mm3, with the exception of pregnant women with HIV, babies born from women with HIV, and PLHIV with TB and Hepatitis B who are not yet on ART (these PLHIV received ART regardless of their CD4 cell count) [5, 6].